InNexus Biotechnology CEO Scheduled as Guest Speaker on Canada’s BNN – Business News Network Channel
Posted on September 18, 2007 - Filed Under Technology
InNexus Biotechnology Inc. ( Nachrichten ) (OTCBB: IXSBF, TSX: IXS), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL
Related posts:
- Brookside Provides Business Update and Third Quarter Financial Results
- eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
- Rim Semiconductor and Ringgold Telephone to Test High-Speed Technology
- IT majors explore business in science
- Rim Semiconductor and Canby Telcom to Test High-Speed Technology
Comments
Leave a Reply